Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

In Vivo Imaging of the Olfactory Epithelium Using Confocal Laser Endomicroscopy

NCT: NCT07546617 · NOT_YET_RECRUITING

NCT IDNCT07546617
StatusNOT_YET_RECRUITING
Start Date2026-07-01
Completion2027-07-31

Brief Summary

This research is being done to better characterize the part of the nose that helps us smell. Currently, the only ways to study smell loss mostly rely on how people report it, rather than being able to see the underlying structures directly. In this study, we will use a special microscope (Confocal Laser Endomicroscopy (CLE)), originally developed for brain tissue, to look at the part of the nose that helps to detects smell. We hope to identify the tiny structures in that area and see how they might be different in people who have smell loss compared to those who do not.

Frequently Asked Questions

What is In Vivo Imaging of the Olfactory Epithelium Using Confocal Laser Endomicroscopy?

In Vivo Imaging of the Olfactory Epithelium Using Confocal Laser Endomicroscopy is a clinical trial registered under NCT07546617. Current status: NOT_YET_RECRUITING.

What is the status of NCT07546617?

The current status of NCT07546617 (In Vivo Imaging of the Olfactory Epithelium Using Confocal Laser Endomicroscopy) is: NOT_YET_RECRUITING.

When did In Vivo Imaging of the Olfactory Epithelium Using Confocal Laser Endomicroscopy start?

In Vivo Imaging of the Olfactory Epithelium Using Confocal Laser Endomicroscopy started on 2026-07-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.